BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference Biotech Investing
Bellus Health, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm Biotech Investing
HempFusion Wellness Inc. To Report First Quarter 2021 Earnings and Host Conference Call on May 17, 2021 Biotech Investing
FINAL DEADLINE APPROACHING: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Champignon Brands Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Psychedelics Investing
LevelJump Announces Commencement of Trading on the OTCQB Venture Market in the United States Medical Device Investing
SOLITON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SOLY and Encourages Investors to Contact the Firm Biotech Investing
Last Few Days to Actively Participate in BELLUS Health Inc. Class Action and Lead Plaintiff Deadline: May 17, 2021 - Bronstein, Gewirtz & Grossman, LLC Biotech Investing
EBON, DOX & SHRMF Class Action Reminders: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Psychedelics Investing
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
Marvel Biosciences Advances MB-204 Toward First-in Human Testing, Selects CMAX as Phase I Clinical Trial Site
